Evidence map›Paper›PMID 35585145›Full record

ArticleNature communications2022

Origins of glycan selectivity in streptococcal Siglec-like adhesins suggest mechanisms of receptor adaptation.

Barbara A Bensing, Haley E Stubbs, Rupesh Agarwal, Izumi Yamakawa, Kelvin Luong, Kemal Solakyildirim, Hai Yu, Azadeh Hadadianpour, Manuel A Castro, Kevin P Fialkowski and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Microbial Lectin-Targeting Mucus: A Glycobioinformatic Approach.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  5. Article
  6. Review
  7. Mutexa: A Computational Ecosystem for Intelligent Protein Engineering.Journal of chemical theory and computation · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Barbara A Bensing *Division of Infectious Diseases, Veterans Affairs Medical Center, Department of Medicine, University of California, San Francisco, CA, USA.
Haley E Stubbs *Graduate Program in Chemical and Physical Biology, Vanderbilt University, Nashville, TN, 37232, USA.
Rupesh AgarwalUniversity of Tennessee/Oak Ridge National Laboratory, Center for Molecular Biophysics, Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831-6309, USA.ORCID 0000-0003-1029-2281
Izumi YamakawaDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.
Kelvin LuongDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.
Kemal SolakyildirimDepartment of Chemistry, Erzincan Binali Yildirim University, Erzincan, 24100, Turkey.
Hai YuDepartment of Chemistry, University of California, Davis, CA, 95616, USA.ORCID 0000-0002-4378-0532
Azadeh HadadianpourDepartment of Microbiology, Pathology, and Immunology, Vanderbilt University, Nashville, TN, 37232, USA.
Manuel A CastroDepartment of Biochemistry, Vanderbilt University, Nashville, TN, 37232, USA.
Kevin P FialkowskiDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.ORCID 0000-0001-6333-505X
KeAndreya M MorrisonDepartment of Pharmacology, School of Graduate Studies and Research, Meharry Medical College, Nashville, TN, 37208, USA.
Zdzislaw WawrzakLS-CAT Synchrotron Research Center, Northwestern University, Argonne, IL, 60439, USA.
Xi ChenDepartment of Chemistry, University of California, Davis, CA, 95616, USA.
Carlito B LebrillaDepartment of Chemistry, University of California, Davis, CA, 95616, USA.ORCID 0000-0001-7190-5323
Jerome BaudryDepartment of Biological Sciences, The University of Alabama in Huntsville, Huntsville, AL, 35899, USA.
Jeremy C SmithUniversity of Tennessee/Oak Ridge National Laboratory, Center for Molecular Biophysics, Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831-6309, USA.
Paul M SullamDivision of Infectious Diseases, Veterans Affairs Medical Center, Department of Medicine, University of California, San Francisco, CA, USA.
T M IversonDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA. tina.iverson@vanderbilt.edu.ORCID 0000-0001-8816-6352
Vanderbilt University · USUniversity of California, Davis · USOak Ridge National Laboratory · USSan Francisco VA Medical Center · USErzincan Binali Yıldırım University · TRMeharry Medical College · USNorthwestern University · USUniversity of Alabama in Huntsville · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Overall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9M
Training in Vision ResearchT32EY007135 · NEI · VANDERBILT UNIVERSITY · PI GEOFFREY F WOODMAN · 1994 to 2026
$5.8M
STREPTOCOCCAL PLATELET BINDING AND ENDOCARDITISR01AI041513 · NIAID · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI SULLAM, PAUL M. · 1997 to 2019
$5.6M
Mechanisms for ligand binding by serine-rich adhesins of Gram-positive pathogensR01AI106987 · NIAID · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI IVERSON, T M, SULLAM, PAUL M. · 2014 to 2018
$3.4M
Protein-Glycan Interaction Resource of the CFGR24GM098791 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D, PAULSON, JAMES C · 2011 to 2013
$2.6M
Supplement: Exploring the biology of O-acetyl sialic acids using stable synthetic mimicsR01AI130684 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI, VARKI, AJIT P · 2017 to 2020
$2.3M
Engineered probes for sialoglycan detectionR01GM137458 · NIGMS · VANDERBILT UNIVERSITY · PI IVERSON, T M · 2020 to 2023
$1.8M
HARNESSING THE ORAL MICROBIOME TO CREATE NOVEL GLYCAN-BINDING PROBESU01CA221244 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUHL, STEFAN HANS-KLAUS, SULLAM, PAUL M. · 2017 to 2019
$1.4M
Using streptococcal sialoglycan binding proteins to characterize MUC7 glycoformsR03DE029516 · NIDCR · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BENSING, BARBARA ANNE · 2020 to 2021
$307k
NCI NIH HHS U01 CA221244NEI NIH HHS T32 EY007135NIAID NIH HHS R01 AI041513NIAID NIH HHS R01 AI106987NIAID NIH HHS R01 AI130684NIDCR NIH HHS R03 DE029516NIGMS NIH HHS P41 GM103393NIGMS NIH HHS P41 GM103694NIGMS NIH HHS R01 GM137458NIGMS NIH HHS R24 GM098791NIGMS NIH HHS T32 GM007628NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

Bacterial binding to host receptors underlies both commensalism and pathogenesis. Many streptococci adhere to protein-attached carbohydrates expressed on cell surfaces using Siglec-like binding regions (SLBRs). The precise glycan repertoire recognized may dictate whether the organism is a strict commensal versus a pathogen. However, it is currently not clear what drives receptor selectivity. Here, we use five representative SLBRs and identify regions of the receptor binding site that are hypervariable in sequence and structure. We show that these regions control the identity of the preferred carbohydrate ligand using chimeragenesis and single amino acid substitutions. We further evaluate how the identity of the preferred ligand affects the interaction with glycoprotein receptors in human saliva and plasma samples. As point mutations can change the preferred human receptor, these studies suggest how streptococci may adapt to changes in the environmental glycan repertoire.

Indexed as

Adhesins, BacterialSialic Acid Binding Immunoglobulin-like LectinsHumansLigandsPolysaccharidesStreptococcusAdhesins, BacterialLigandsPolysaccharidesSialic Acid Binding Immunoglobulin-like Lectins

Identifiers

PMID35585145
PMCPMC9117288
OpenAlexW4280583207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.